SUBSCRIBE
SUBSCRIBE

Sanofi (France)

NEWS
BioCapital
Pharma Plays With Fire
April 26, 2006
 · 
1 min read
Merck & Co., Inc. Cervical Cancer Shot Gives 5-Year Protection
April 26, 2006
 · 
1 min read
BioCapital
Antibiotic May Help Asthma Attacks
April 13, 2006
 · 
1 min read
BioCapital
Pharmaceuticals: Blindsided
April 3, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Sanofi-Aventis (France) Adds To Generics Business
March 27, 2006
 · 
1 min read
Policy
Sanofi-Aventis (France) Defends Ambien Sleeping Pill
March 23, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Sanofi-Aventis (France) And Bristol-Myers Squibb Company Climb On Plavix Settlement
March 22, 2006
 · 
1 min read
BioMidwest
Sanofi-Aventis (France) Ambien May Prompt Sleep-Eating
March 15, 2006
 · 
1 min read
Doubt Cited On Aspirin-Blood Thinner Combo
March 13, 2006
 · 
1 min read
Load More
JOBS
IN THE PRESS
Press Releases
Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA
December 29, 2025
 · 
5 min read
Press Releases
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
December 24, 2025
 · 
13 min read
Press Releases
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
December 24, 2025
 · 
11 min read
Press Releases
Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia
December 24, 2025
 · 
9 min read
Press Releases
Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
December 23, 2025
 · 
23 min read
Press Releases
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
December 23, 2025
 · 
14 min read
Press Releases
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
December 22, 2025
 · 
7 min read
Press Releases
Press release: Availability of the Q4 2025 Aide memoire
December 17, 2025
 · 
4 min read
Press Releases
Press Release: Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema
December 17, 2025
 · 
6 min read
Press Releases
ADEL Signs $1.04 Billion Global License Agreement with Sanofi for ADEL-Y01, a Novel investigational Alzheimer’s Disease Therapy
December 16, 2025
 · 
2 min read
Load More